Friulchem SpA banner

Friulchem SpA
MIL:FCM

Watchlist Manager
Friulchem SpA Logo
Friulchem SpA
MIL:FCM
Watchlist
Price: 0.81 EUR 2.53% Market Closed
Market Cap: €6.5m

Friulchem SpA
Cash from Investing Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Friulchem SpA
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Friulchem SpA
MIL:FCM
Cash from Investing Activities
-€6.9m
CAGR 3-Years
-37%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Cash from Investing Activities
-€13.7m
CAGR 3-Years
-251%
CAGR 5-Years
-86%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Cash from Investing Activities
-€80.8m
CAGR 3-Years
53%
CAGR 5-Years
9%
CAGR 10-Years
-9%
No Stocks Found

Friulchem SpA
Glance View

Market Cap
6.5m EUR
Industry
Pharmaceuticals

Friulchem SpA engages in the research and development of pharmaceutical products for third party contract development and manufacturing organizations. The company is headquartered in Vivaro, Pordenone and currently employs 37 full-time employees. The company went IPO on 2019-07-25.

FCM Intrinsic Value
Not Available

See Also

What is Friulchem SpA's Cash from Investing Activities?
Cash from Investing Activities
-6.9m EUR

Based on the financial report for Dec 31, 2023, Friulchem SpA's Cash from Investing Activities amounts to -6.9m EUR.

What is Friulchem SpA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-49%

Over the last year, the Cash from Investing Activities growth was -192%. The average annual Cash from Investing Activities growth rates for Friulchem SpA have been -37% over the past three years , -49% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett